NGM Biopharmaceuticals, Inc. Debt to Equity Ratio 2018-2023 | NGM
Current and historical debt to equity ratio values for NGM Biopharmaceuticals, Inc. (NGM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. NGM Biopharmaceuticals, Inc. debt/equity for the three months ending December 31, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.02B | $0.15B | 0.14 |
| 2023-09-30 | $0.02B | $0.17B | 0.13 |
| 2023-06-30 | $0.03B | $0.19B | 0.15 |
| 2023-03-31 | $0.04B | $0.22B | 0.17 |
| 2022-12-31 | $0.05B | $0.26B | 0.18 |
| 2022-09-30 | $0.05B | $0.29B | 0.18 |
| 2022-06-30 | $0.05B | $0.29B | 0.16 |
| 2022-03-31 | $0.05B | $0.31B | 0.16 |
| 2021-12-31 | $0.07B | $0.34B | 0.20 |
| 2021-09-30 | $0.06B | $0.35B | 0.18 |
| 2021-06-30 | $0.05B | $0.37B | 0.13 |
| 2021-03-31 | $0.05B | $0.40B | 0.12 |
| 2020-12-31 | $0.05B | $0.28B | 0.18 |
| 2020-09-30 | $0.05B | $0.28B | 0.18 |
| 2020-06-30 | $0.05B | $0.30B | 0.15 |
| 2020-03-31 | $0.04B | $0.32B | 0.13 |
| 2019-12-31 | $0.05B | $0.33B | 0.15 |
| 2019-09-30 | $0.05B | $0.34B | 0.15 |
| 2019-06-30 | $0.05B | $0.35B | 0.15 |
| 2019-03-31 | $0.35B | $-0.12B | -2.94 |
| 2018-12-31 | $0.35B | $-0.11B | -3.27 |
| 2018-09-30 | $0.00B | $0.00B | 0.00 |
| 2018-06-30 | $0.00B | $0.00B | 0.00 |
| 2018-03-31 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.00B | $0.00B | 0.00 |
